ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2204

Clinical Utility of a Multi-Energy Spectral CT in Crystal Arthritis

Lisa K. Stamp1, Nigel Anderson2, Fabio Becce3, Maya Rajeswari2, Matthew Polson4, Olivier Guyen3, Anais Viry3, Chloe Choi2, Tracy Kirkbride5 and Aamir Raja2, 1University of Otago, Christchurch, New Zealand, 2University of Otago, Christchurch, Christchurch, New Zealand, 3Lausanne University Hospital, Lausanne, Switzerland, 4University of Canterbury, Christchurch, New Zealand, 5Ara Institute of Canterbury, Christchurch, New Zealand

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Calcium pyrophosphate dihydrate (CPPD), gout and radiology

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 23, 2018

Title: Imaging of Rheumatic Diseases Poster III: Other Modalities

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: The gold standard for the diagnosis of crystal-related arthritis requires aspiration and visualization of crystals from synovial fluid or tophus material. However, crystal identification may be suboptimal particularly for crystals other than monosodium urate (MSU) which are associated with gout. New imaging modalities such as ultrasound and dual energy CT are increasingly being used to aid in the diagnosis of gout but their role is less well defined in other crystal deposition diseases. The ability to characterise calcium pyrophosphate (CPP) or hydroxyapatite (HA) crystals using non-invasive imaging would be an advance. The aim of this study was to determine whether we could detect and differentiate between MSU, CPP and HA crystals using novel multi-energy spectral CT (MARS) imaging.

Methods: A finger with a gouty tophus from the Christchurch Cancer Tissue bank and a calcified medial meniscus excised at the time of joint replacement surgery were obtained. The gouty finger was imaged using plain X-ray, DECT and a preclinical MARS scanner. Images of the whole meniscus using plain X-ray and MARS were obtained. MARS imaging of biological specimens and calibration phantoms containing known concentrations of MSU, CPP and HA crystals was performed using energy thresholds of 20, 30, 40 and 50 keV at 80 kVp. Material decomposition was applied to the imaging data to distinguish MSU, CPP and HA crystals. For validation purposes, samples of the crystals were obtained from the meniscus and tophus and examined by x-ray diffraction (XRD) and polarized microscopy respectively.

Results: Plain X-ray of the gouty finger revealed erosions and changes consistent with a tophus (Figure 1a). DECT and MARS both identified MSU crystals, however, MARS was able to detect finer detail (Figure 1b). Within the meniscus plain X-ray identified chondrocalcinosis consistent with CPP crystals while MARS showed a predominance of CPP crystals in the calcified regions in the excised meniscus and in some parts there was a mixture of HA and CPP (Figure 1d). MARS imaging findings of the meniscus were validated using x-ray diffraction of the crystal scrapings.

Conclusion: MARS spectral CT can not only detect and differentiate MSU crystals in a gouty finger but also specifically detect and identify CPP within an osteoarthritic human knee meniscus and distinguish them from HA crystals. There is potential for MARS to become useful in the diagnosis of crystal-related arthropathies including CPPD, gout and calcific tendonitis.

Figure  

 


Disclosure: L. K. Stamp, Amgen Inc., 8; N. Anderson, None; F. Becce, None; M. Rajeswari, None; M. Polson, None; O. Guyen, None; A. Viry, None; C. Choi, None; T. Kirkbride, None; A. Raja, None.

To cite this abstract in AMA style:

Stamp LK, Anderson N, Becce F, Rajeswari M, Polson M, Guyen O, Viry A, Choi C, Kirkbride T, Raja A. Clinical Utility of a Multi-Energy Spectral CT in Crystal Arthritis [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/clinical-utility-of-a-multi-energy-spectral-ct-in-crystal-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/clinical-utility-of-a-multi-energy-spectral-ct-in-crystal-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology